Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Exploring the dark side of the moon: the treatment of benzodiazepine tolerance.

Literature DB >> 23617374

Exploring the dark side of the moon: the treatment of benzodiazepine tolerance.

Fabio Lugoboni¹, Gianluca Quaglio.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2014 PMID： 23617374 PMCID： PMC4014016 DOI： 10.1111/bcp.12148

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

17 in total

1. Megadose bromazepam and zolpidem dependence: two case reports of treatment with flumazenil and valproate.

Authors: Gianluca Quaglio; Marco Faccini; Caroline Victorri Vigneau; Rebecca Casari; Sophie Mathewson; Manuela Licata; Fabio Lugoboni
Journal: Subst Abus Date: 2012 Impact factor: 3.716

2. What is stopping us from using flumazenil?

Authors: Fabio Lugoboni; Roberto Leone
Journal: Addiction Date: 2012-04-17 Impact factor: 6.526

3. Focal nonconvulsive seizures during detoxification for benzodiazepine abuse.

Authors: Anna Albiero; Francesco Brigo; Marco Faccini; Rebecca Casari; Gianluca Quaglio; Monica Storti; Antonio Fiaschi; Luigi Giuseppe Bongiovanni; Fabio Lugoboni
Journal: Epilepsy Behav Date: 2011-12-24 Impact factor: 2.937

4. Dependence on zolpidem: two case reports of detoxification with flumazenil infusion.

Authors: GianLuca Quaglio; Fabio Lugoboni; Anna Fornasiero; Alessandro Lechi; Gilberto Gerra; Paolo Mezzelani
Journal: Int Clin Psychopharmacol Date: 2005-09 Impact factor: 1.659

5. The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study.

Authors: C de las Cuevas; E J Sanz; J A de la Fuente; J Padilla; J C Berenguer
Journal: Addiction Date: 2000-02 Impact factor: 6.526

6. Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study.

Authors: Shao-You Fang; Chuan-Yu Chen; I-Shou Chang; Erin Chia-Hsuan Wu; Chia-Ming Chang; Keh-Ming Lin
Journal: Drug Alcohol Depend Date: 2009-06-09 Impact factor: 4.492

7. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.

Authors: G Gerra; A Zaimovic; F Giusti; G Moi; C Brewer
Journal: Addict Biol Date: 2002-10 Impact factor: 4.280

Exploring the dark side of the moon: the treatment of benzodiazepine tolerance.

1. Megadose bromazepam and zolpidem dependence: two case reports of treatment with flumazenil and valproate.

2. What is stopping us from using flumazenil?

3. Focal nonconvulsive seizures during detoxification for benzodiazepine abuse.

4. Dependence on zolpidem: two case reports of detoxification with flumazenil infusion.

5. The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study.

6. Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study.

7. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.

8. Benzodiazepines and injurious falls in community dwelling elders.

9. The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles.

10. Lormetazepam addiction: data analysis from an Italian medical unit for addiction.

1. Dopaminergic control of anxiety in young and aged zebrafish.

Review 2. The problems of long-term treatment with benzodiazepines and related substances.

Review 3. Withdrawing Benzodiazepines in Patients With Anxiety Disorders.

4. Surviving Benzodiazepines: A Patient's and Clinician's Perspectives.